Joshua Di Vincenzo
MSc researcher / clinical research staff member at the University Health Network and University of Toronto
Papers
8 publications
Trials
0 clinical trials
Key Impact
He coauthors multiple systematic reviews and real-world studies on ketamine for treatment-resistant depression, making him a visible contributor to the evidence base on psychedelic-adjacent psychiatric therapeutics.
Background & Research
Joshua D. Di Vincenzo appears in the psychiatric ketamine literature as a researcher based at the University Health Network in Toronto and the University of Toronto. ClinicalTrials.gov lists him as a study contact for mood-disorder trials, and PubMed records show him as an author on multiple ketamine-focused reviews and real-world effectiveness studies.
Collaboration Network
20 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersTreatment-Resistant Depression (TRD)SuicidalityAnxiety DisordersMajor Depressive Disorder (MDD)Bipolar DisorderPublic Health, Prevention & Behaviour ChangeSafety & Risk ManagementBorderline Personality Disorder (BPD)Personality DisordersNeuroimaging & Brain MeasuresChronic PainImmunology & InflammationAdolescentsOlder AdultsSchizophrenia